BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26045802)

  • 21. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
    Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
    Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
    Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
    Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between prognosis and expression of metastasis-associated protein 1 in stage I non-small cell lung cancer.
    Yu Y; Wang Z; Zhang MY; Liu XY; Zhang H
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):166-9. PubMed ID: 20935042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
    Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
    Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of nestin expression in resected non-small cell lung cancer.
    Ryuge S; Sato Y; Wang GQ; Matsumoto T; Jiang SX; Katono K; Inoue H; Satoh Y; Masuda N
    Chest; 2011 Apr; 139(4):862-869. PubMed ID: 20829334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
    Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
    Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.
    Stewart RL; West D; Wang C; Weiss HL; Gal T; Durbin EB; O'Connor W; Chen M; O'Connor KL
    Hum Pathol; 2016 Aug; 54():174-83. PubMed ID: 27107458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
    Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM
    Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
    Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
    J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients.
    Park S; Choi YL; Sung CO; An J; Seo J; Ahn MJ; Ahn JS; Park K; Shin YK; Erkin OC; Song K; Kim J; Shim YM; Han J
    Histol Histopathol; 2012 Feb; 27(2):197-207. PubMed ID: 22207554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer.
    Qiu ZX; Wang L; Han J; Liu D; Huang W; Altaf K; Qiu XS; Javed MA; Zheng J; Chen BJ; Li WM
    Cancer Sci; 2012 Oct; 103(10):1774-9. PubMed ID: 22738312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma.
    Vigouroux C; Casse JM; Battaglia-Hsu SF; Brochin L; Luc A; Paris C; Lacomme S; Gueant JL; Vignaud JM; Gauchotte G
    Lung Cancer; 2015 Aug; 89(2):189-96. PubMed ID: 26013954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC.
    Petersen LF; Klimowicz AC; Otsuka S; Elegbede AA; Petrillo SK; Williamson T; Williamson CT; Konno M; Lees-Miller SP; Hao D; Morris D; Magliocco AM; Bebb DG
    Oncotarget; 2017 Jun; 8(24):38326-38336. PubMed ID: 28418844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression profile of apoptosis-related molecules correlated with clinicopathological factors in non-small-cell lung cancer.
    Huang JQ; Liang HL; Jin TE; Xie Z
    Int J Clin Exp Pathol; 2015; 8(9):11278-86. PubMed ID: 26647102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.
    Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J
    Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological significance of fibroblast growth factor 1 in non-small cell lung cancer.
    Li J; Wei Z; Li H; Dang Q; Zhang Z; Wang L; Gao W; Zhang P; Yang D; Liu J; Sun Y; Gao W
    Hum Pathol; 2015 Dec; 46(12):1821-8. PubMed ID: 26391572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer.
    Pøhl M; Olsen KE; Holst R; Donnem T; Busund LT; Bremnes RM; Al-Saad S; Andersen S; Richardsen E; Ditzel HJ; Hansen O
    Acta Oncol; 2016; 55(2):167-77. PubMed ID: 26057535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.